Persistent psychosis after treatment with interferon alpha: a case report.
Telio
David
D
Sockalingam
Sanjeev
S
Stergiopoulos
Vicky
V
D014150:Antipsychotic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology*
D014150:Antipsychotic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D001569:Benzodiazepines; D000077152:Olanzapine